|
Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations
|
September 9, 2022
|
PC3I Authors Charu Aggarwal |
Cancers (Basel)
|
|
Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs
|
September 5, 2022
|
PC3I Authors George Demiris |
Lancet Regional Health
|
|
Predictive value of 5-Factor modified frailty index in Oncologic and benign hysterectomies
|
September 2, 2022
|
PC3I Authors Emily Ko |
Gynecologic Oncology Reports
|
|
Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors
|
August 29, 2022
|
PC3I Authors Kerry Coughlin; Larry Shulman; Ronac Mamtani |
JAMA Network Open
|
|
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
|
August 29, 2022
|
PC3I Authors Likhitha Kolla |
ArXiv
|
|
Disparities in biomarker testing in ovarian cancer: a real-world analysis
|
August 25, 2022
|
PC3I Authors Anna Jo Smith; Emily Ko |
American Journal of Obstetrics and Gynecology
|
|
Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
|
August 23, 2022
|
PC3I Authors |
JAMA Network Open
|
|
Oncologist Perceptions of Algorithm-Based Nudges to Prompt Early Serious Illness Communication: A Qualitative Study
|
August 19, 2022
|
PC3I Authors William Ferrell |
Journal of Palliative Medicine
|
|
Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa
|
August 18, 2022
|
PC3I Authors Surbhi Grover |
JCO Global Oncology
|
|
Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors
|
August 18, 2022
|
PC3I Authors Christopher A. D’Avella |
JAMA Otolaryngology - Head and Neck Surgery
|
|
“I Know That I Was a Part of Making a Difference”: Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption
|
August 18, 2022
|
PC3I Authors Katharine Rendle |
AIDS Research and Human Retroviruses
|
|
Circulating endothelial cells and the study of vascular injury in children undergoing hematopoietic stem cell transplant
|
August 18, 2022
|
PC3I Authors Alix Seif |
Haematologica
|
|
Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017
|
August 17, 2022
|
PC3I Authors Justin Bekelman |
JAMA Health Forum
|
|
Rural-Urban Disparities in Mortality and Place of Death for Gastrointestinal Cancer in the United States From 2003 to 2019
|
August 13, 2022
|
PC3I Authors Ramy Sedhom |
Gastroenterology
|
|
Radiology for Thoracic Conditions in Low- and Middle-Income Countries
|
August 12, 2022
|
PC3I Authors Farouk Dako |
Thoracic Surgery Clinics
|
|
Peripheral blood leukocyte mitochondrial DNA content and risk of lung cancer
|
August 12, 2022
|
PC3I Authors Anil Vachani |
Translational Lung Cancer Research
|
|
A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
|
August 12, 2022
|
PC3I Authors Haley Newman |
International Journal of Molecular Sciences
|
|
Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups
|
August 11, 2022
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Annals of Surgical Oncology
|
|
Expanding the Reach of Lung Cancer Screening: Risk Models for Individuals Who Never Smoked
|
August 11, 2022
|
PC3I Authors Anil Vachani |
American Journal of Respiratory and Critical Care Medicine
|
|
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
|
August 11, 2022
|
PC3I Authors Charu Aggarwal |
JCO Precision Oncology
|
